Amgen, Inc.
(NASDAQ : AMGN)

( )
AMGN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.08%61.590.0%$953.82m
GILDGilead Sciences, Inc. -1.14%76.061.0%$768.72m
AMGNAmgen, Inc. 8.17%255.121.3%$748.85m
REGNRegeneron Pharmaceuticals, Inc. -2.32%609.172.5%$678.56m
NVAXNovavax, Inc. -4.38%79.70102.0%$606.94m
BIIBBiogen, Inc. -1.04%264.771.6%$543.38m
VRTXVertex Pharmaceuticals, Inc. -1.39%286.281.9%$524.18m
ILMNIllumina, Inc. -0.49%368.553.5%$308.59m
ALXNAlexion Pharmaceuticals, Inc. 0.13%112.392.0%$229.11m
BMRNBioMarin Pharmaceutical, Inc. 2.03%125.844.3%$214.73m
SGENSeattle Genetics, Inc. -1.41%167.526.1%$201.85m
SRNESorrento Therapeutics, Inc. 10.35%6.931.8%$186.93m
SRPTSarepta Therapeutics, Inc. 3.33%165.6813.9%$168.66m
INCYIncyte Corp. -1.27%102.652.5%$160.00m
IMMUImmunomedics, Inc. 4.15%36.9111.0%$154.32m

Company Profile

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.